Dupont Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-159
| Closed | -$66.9K | – | 803 |
|
|
2022
Q4 | $66.9K | Sell |
159
-114
| -42% | -$47.9K | ﹤0.01% | 1024 |
|
|
2022
Q3 | $114K | Buy |
273
+123
| +82% | +$51.4K | 0.01% | 991 |
|
|
2022
Q2 | $74K | Sell |
150
-497
| -77% | -$245K | ﹤0.01% | 1231 |
|
|
2022
Q1 | $364K | Buy |
647
+58
| +10% | +$32.6K | 0.01% | 875 |
|
|
2021
Q4 | $445K | Sell |
589
-1,227
| -68% | -$927K | 0.02% | 854 |
|
|
2021
Q3 | $1.36M | Sell |
1,816
-532
| -23% | -$397K | 0.04% | 446 |
|
|
2021
Q2 | $1.51M | Sell |
2,348
-2,383
| -50% | -$1.54M | 0.04% | 436 |
|
|
2021
Q1 | $2.7M | Buy |
4,731
+1,799
| +61% | +$1.03M | 0.07% | 258 |
|
|
2020
Q4 | $1.71M | Sell |
2,932
-978
| -25% | -$570K | 0.04% | 379 |
|
|
2020
Q3 | $2.02M | Sell |
3,910
-880
| -18% | -$454K | 0.04% | 307 |
|
|
2020
Q2 | $2.16M | Sell |
4,790
-360
| -7% | -$163K | 0.05% | 298 |
|
|
2020
Q1 | $1.81M | Sell |
5,150
-964
| -16% | -$338K | 0.04% | 314 |
|
|
2019
Q4 | $2.26M | Buy |
6,114
+1,909
| +45% | +$706K | 0.05% | 325 |
|
|
2019
Q3 | $1.4M | Buy |
4,205
+1,246
| +42% | +$415K | 0.03% | 429 |
|
|
2019
Q2 | $925K | Buy |
2,959
+1,100
| +59% | +$344K | 0.02% | 570 |
|
|
2019
Q1 | $568K | Sell |
1,859
-200
| -10% | -$61.1K | 0.01% | 715 |
|
|
2018
Q4 | $478K | Buy |
+2,059
| New | +$478K | 0.01% | 749 |
|